RxDoctor Payments Data

Rito Munoz, PA

Physician Assistant · Fort Worth, TXNPI 1154761195

Payments from drug & device makers

$1,833in general payments, 2019–2025

Across 121 payments — averaging $15.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$402
  • Novo Nordisk$368
  • Lilly USA, LLC$202
  • AstraZeneca$199
  • Merck$160
  • Bayer$143
  • plus $359 from 8 others

What the payments were for

  • Food & beverage$1,833100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,833 in reported general payments places this provider in the 75th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$3,400
Medicare patients
18
Services billed
60

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin77$142,103
JanuviaSitagliptin Phosphate48$80,355
TrulicityDulaglutide33$75,857
EliquisApixaban37$43,974
Tresiba Flextouch U-200Insulin Degludec46$42,558
RybelsusSemaglutide16$41,443
Janumet XrSitagliptin Phos/Metformin Hcl24$37,055
MyrbetriqMirabegron25$36,826
MounjaroTirzepatide26$30,677
LinzessLinaclotide26$27,649
TradjentaLinagliptin19$25,780
FarxigaDapagliflozin Propanediol21$24,499
Xigduo XrDapaglifloz Propaned/Metformin14$19,066
Gabapentin117$3,541
Omeprazole106$3,110

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$402$167,88396 claims
MerckJanuvia, Janumet Xr$160$117,40972 claims
Lilly USA, LLCTrulicity, Mounjaro$202$106,53459 claims
PfizerEliquis$43$43,97437 claims
Novo NordiskRybelsus$368$41,44316 claims
AbbVieLinzess$38$27,64926 claims
AstraZenecaFarxiga$199$24,49921 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →